Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Catonsville › NPI 1659094753
Clinic

Bhmat Consulting LLC

Bhmat Consulting LLC was paid $2.10M by Medicaid between Sep 2023 and Dec 2024, across 3 billing codes. Its largest line is G0480, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed — 87% of everything it billed.

33Billing provider infoBHMAT CONSULTING LLC
CATONSVILLE, MD 21228
33aNPI1659094753assigned 09/22/2022
33bProvider typeClinic/Center
28Total paid$2.10M
24GClaims22,518
24DCodes billed3
24AFirst – last monthSep 2023 – Dec 2024
Compared with peers

Next to other Clinic/Center providers in Maryland

Rank by total paid#14 of 110
Median peer was paid$213K
This provider vs. median9.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official COLES, ISIAH controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20235,242$505K
2024incomplete17,276$1.60M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 87% 20,314 14,317 $1.84M
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 12% 2,095 1,855 $261K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 109 109 $5K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOLES, ISIAH (CEO)
Same official

Other billing entities under COLES, ISIAH

Full network →
ProviderLocationPaid
Outreach Recovery II, LLCLaurel, MD$20.11M
Outreach Recovery II, LLCCumberland, MD$1.87M
Outreach Recovery II, LLCCumberland, MD$1.01M
Outreach Recovery II, LLCWaldorf, MD$908K
Outreach Recovery IIAnnapolis, MD$802K
Outreach Recovery II, LLCGlen Burnie, MD$686K
Outreach Recovery II, LLCHagerstown, MD$619K
Outreach Recovery II, LLCFrederick, MD$618K
Outreach Recovery IIGreat Mills, MD$412K
Outreach Recovery II, LLCWaldorf, MD$229K
Outreach Recovery IIBaltimore, MD$228K
Outreach Recovery IIEaston, MD$215K
Outreach Recovery II, LLCHagerstown, MD$173K
Outreach Recovery IICatonsville, MD$98K
Outreach Recovery II, LLCLexington Park, MD$4K
Outreach Recovery II, LLCBaltimore, MD$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.